glp 1 euglycemic dka When the Transition Goes Wrong: A Rare Case of Diabetic Ketoalkalosis After Transitioning to Tirzepatide in Insulin-dependent Type 2 Diabetes Life-Saving Awareness: Recognizing and Preventing

Additional information

The schedule your provider sets may depend on several factors: Initial Lab Results: If your baseline labs showed any borderline values, your provider might want to monitor you more frequently

van Duynhoven, J., et al

Well handle the rest

In addition to the possible health risks associated with the use of GLP-1 drugs, these therapies are associated with a high out-of-pocket cost for individuals who do not qualify for their use through insurance, such as those wanting to lose weight without falling into the obesity or diabetes categories

Nausea Nausea is one of the most reported side effects, especially during the first few doses